Report will be released at 8.00am CET and conference call at 10.00 am CET.
Info about conference call/webcast: Ascelia Pharma, Audiocast with teleconference, Q4, 2020 | Financial Hearings
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.
Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)
Download our fact sheet: Ascelia Pharma Factsheet Dec 2020
Company presentation (pdf)
